News

In the global chemical trade landscape, every cooperation with new customers is like an adventure full of unknowns. Bloom Tech, as a company deeply...

On March 18, 2026, Zhongxin Biotechnology announced that the US Food and Drug Administration (FDA) has approved its clinical trial (IND) applicatio...

On March 16, 2026, Structure Therapeutics announced that Alenigliffon, which is used to treat patients with obesity/overweight and at least one wei...

On March 12, 2026, the Clinicaltrial website showed that Smeglutide nasal spray of Shiling Pharmaceutical had registered a phase | clinical study i...

We recently received our first valuable OEM capsule order from a new customer in the United States, marking our continued steady expansion in the N...

We recently secured a first-time order for our BLOOM TECH's Retatrutide products from an Australian customer, marking a significant milestone i...

On January 14, 2026, Zhejiang Daoer Biotechnology Co., Ltd. (hereinafter referred to as "Daoer Biotechnology"), a subsidiary of East Chin...

On January 13, 2026, China Biopharmaceuticals (1177. HK) announced that it will fully acquire Hangzhou Hejiya Biopharmaceutical Co., Ltd. (hereinaf...

Recently, Xinlitai announced that its independently developed innovative drug SAL0145 Injection (project code: SALO0145) for the treatment of metab...

On January 7, 2026, Aktis0ncol0gy, a biopharmaceutical company specializing in targeted radiopharmaceuticals, announced its expanded initial public...

We recently secured an order from a Vietnamese customer for two specifications of BLOOM TECH's Tirzepatide , marking a successful step in our V...

A German peptide client searched for products on Google, found Bloom Tech, and sent an inquiry expressing interest in shipping the products to Germ...